United Therapeutics Corp
(NAS:UTHR)
$
360.87
-2.78 (-0.76%)
Market Cap: 16.11 Bil
Enterprise Value: 13.18 Bil
PE Ratio: 15.85
PB Ratio: 2.64
GF Score: 86/100 United Therapeutics Corp at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 08:50PM GMT
Release Date Price:
$262.84
(-1.48%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Perfect. Welcome, everyone, to Annual Healthcare Conference at Credit Suisse. I'm Tiago Fauth. I'm one of the lead analyst in the biotech franchise here. We're joined today by United Therapeutics. So Pat and Dewey. So thank you very much for joining us.
Patrick Poisson
United Therapeutics Corporation - Executive VP of Technical Operations
Thank you.
Dewey Steadman
United Therapeutics Corporation - Head of IR
Thank you for having us. Can I mention really quick that Pat and I may make forward-looking statements in our presentation today. And we caution you to review the risks and uncertainties associated with these disclosures in our SEC filings, particularly Forms 10-K and 10-Q that are available on the SEC website. Thank you.
Questions & Answers
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
There you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot